What risk should justify implantable cardioverter defibrillator therapy

American Journal of Cardiology

Volumn 83, Issue 5 B, 1999, Pages

  Schlapfer J ^a   Kappenberger, L ^a   Fromer, M ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVERSION; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DEFIBRILLATOR; HEART VENTRICLE TACHYCARDIA; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; SUDDEN DEATH; TREATMENT OUTCOME;

EID: 0344923761     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)01010-8     Document Type: Conference Paper

References (31)

1. Mirowski M., Reid P.R., Mower M.M., Watkins L., Gott V.L., Schauble J.F., Langer A., Heilman M.S., Kolenik S.A., Fischell R.E., Weisfeldt M.L. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 303:1980;322-324.
2. Winkle R.A., Stinson E.B., Echt D.S., Mead R.H., Schmidt P. Practical aspects of automatic cardioverter/defibrillator implantation. Am Heart J. 108:1984;1335-1346.
3. Echt D.S., Armstrong K., Schmidt P., Oyer P.E., Stinson E.B., Winkle R.A. Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter-defibrillator. Circulation. 71:1985;289-296.
4. Winkle R.A., Mead R.H., Ruder M.A., Gaudani V.A., Smith N.A., Buch W.S., Schmidt P., Shipman T. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol. 13:1989;1353-1361.
5. Fromer M., Schläpfer J., Fischer A., Kappenberger L. Experience with a new implantable pacer-, cardioverter-, defibrillator for the therapy of recurrent sustained ventricular tachyarrhythmias a step toward a universal ventricular tachyarrhythmia control device . PACE Pacing Clin Electrophysiol. 14:1991;1288-1298.
6. Gregoratos G., Cheitlin M., Conill A., Epstein A.E., Fellows C., Ferguson T.B., Freeman R.A., Hlatky M.A., Naccarelli G.V., Saksena S., Schlant R.C., Silka M.J. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee on pacemaker implantation). J Am Coll Cardiol. 31:1998;1175-1209.
7. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 335:1996;1933-1940.
8. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 337:1997;1576-1583.
9. Connoly SJ. Canadian implantable defibrillator study (CIDS). Oral communication at the 47th Annual Scientific Session of the American College of Cardiology, 1998.
10. Kuck KH. Hamburg Cardiac Arrest Study (CASH). Oral communication at the 47th Annual Scientific Session of the American College of Cardiology, 1998.
11. Bigger J.T. Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med. 337:1997;1569-1575.
12. Brugada P., Wellens F., Andries E. A prophylactic implantable cardioverter-defibrillator? Am J Cardiol. 78:(suppl 5A):1996;128-133.
13. Wilber D.J., Kall J.G., Kopp D.E. What can we expect from prophylactic implantable defibrillators? Am J Cardiol. 80:(suppl):1997;20F-27F.
14. Myerburg R.J., Kessler K.M., Castellanos A. Sudden cardiac death epidemiology, transient risk, and intervention assessment . Ann Intern Med. 119:1993;1187-1197.
15. Myerburg R.J., Interian A., Mitrani R.M., Kessler K.M., Castellanos A. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol. 80:(suppl):1997;10F-19F.
16. Myerburg R.J., Castellanos A. Clinical trials of implantable defibrillators. N Engl J Med. 337:1997;1621-1623.
17. Willems A.R., Tijssen J.G.P., van Cappele F.J.L., Kingma J.H., Hauer R.N.W., Vermeulen F.E.E., Brugada P., van Hoogenhuyze D.C.A., Janse M.J. Determinants of prognosis in symptomatic ventricular tachyardia or ventricular fibrillation late after myocardial infarction. J Am Coll Cardiol. 16:1990;521-530.
18. Richard D.A.B., Byth K., Ross D.L., Uther J.B. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction? Circulation. 83:1991;756-763.
19. Farrell T.G., Bashir Y., Cripps T., Malik M., Poloniecki J., Bennett E.D., Ward D.E., Camm A.J. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables, and the signal-averaged electrogram. J Am Coll Cardiol. 18:1991;687-697.
20. Pedretti R., Etro M.D., Laporta A., Braga S.S., Carù B. Prediction of late arrhythmic events after myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia. Am J Cardiol. 71:1993;1131-1141.
21. Wellens H.J.J. Sudden death late after a myocardial infarction substrate and risk stratification . Akhtar M., Myerburg R.J., Ruskin J.N. Sudden Cardiac Death. Prevalence, Mechanisms, and Approaches to Diagnosis and Management. 1994;147-154 Williams and Wilkins, Philadelphia.
22. Pratt C., Waldo A.L., Camm A.J. Can antiarrhythmic drugs survive trials? Am J Cardiol. 81:(suppl):1998;24D-34D.
23. Valenti R., Schläpfer J., Fromer M., Fischer A., Kappenberger L. Impact of the implantable cardioverter-defibrillator on rehospitalisations. Eur Heart J. 17:1996;1565-1571.
24. Friedman P.L., Stevenson W.G. Unsustained ventricular tachycardia to treat or not to treat . N Engl J Med. 335:1996;1984-1985.
25. Mushlin A.I., Hall W.J., Zwantiger J., Gajary E., Andrews M., Marron R., Zou K.H., Moss A.J. The cost-effectiveness of automatic implantable cardiac defibrillators results from MADIT . Circulation. 97:1998;2129-2135.
26. Buxton A.E., Fisher J.D., Josephson M., Lee K.L., Pryor D.B., Prystowsky E.N., Simson M.B., DiCarlo L., Echt D.S., Packer D. Prevention of sudden cardiac death in patients with coronary artery disease the multicenter unsustained tachycardia trial (MUSTT) . Prog Cardiovasc Dis. 36:1993;215-226.
27. Uretsky B.F., Sheahan R.G. Primary prevention of sudden cardiac death in heart failure will the solution be shocking? J Am Coll Cardiol. 30:1997;1589-1597.
28. Primo Joao, Geelen P., Brugada J., Lorga Filho A., Mont L., Wellens F., Valentino M., Brugada P. Hypertrophic cardiomyopathy role of the implantable cardioverter-defibrillator . J Am Coll Cardiol. 31:1998;1081-1085.
29. Zhu D.W., Sun H., Hill R., Roberts R. The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy. PACE Pacing Clin Electrophysiol. 21:1998;299-302.
30. Stevenson W.G., Stevenson L.W., Middlekauff H.R., Saxon L.A. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation. 88:1993;2953-2961.
31. Trappe H.-J., Wenzlaff P. Cardioverter defibrillator therapy as a bridge to heart transplantation. PACE Pacing Clin Electrophysiol. 18:1995;622-631.